45260-7
HIV ART medication
Active
Term Description
The nameof the HIV ART Medication prescribed for the patient as described in the ACTG (AIDS Clinical Trials Group) Adherence Follow Up Questionnaire.
Source: Regenstrief LOINC
Fully-Specified Name
- Component
- HIV ART medication
- Property
- Type
- Time
- Pt
- System
- ^Patient
- Scale
- Qn
- Method
- Reported.ACTG
Additional Names
- Short Name
- HIV ART Rx
Basic Attributes
- Class
- ART
- Type
- Clinical
- First Released
- Version 2.17
- Last Updated
- Version 2.67
Example Units
| Unit | Source |
|---|---|
| wk | Example UCUM Units |
LOINC Terminology Service (API) using HL7® FHIR® Get Info
Requests to this service require a free LOINC username and password. Below is a sample of the possible capabilities. See the LOINC Terminology Service documentation for more information.
- CodeSystem lookup
- https:
//fhir.loinc.org/CodeSystem/$lookup?system=http: //loinc.org&code=45260-7
Copyright
- Organization
- World Health Organization (WHO)
- Copyright
- Copyright © 2006 World Health Organization.
- Terms of Use
- Used with permission. Publications of the World Health Organization can be obtained from WHO Press, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland (tel: +41 22 791 2476; fax: +41 22 791 4857; email: bookorders@who.int). Requests for permission to reproduce or translate WHO publications - whether for sale or for noncommercial distribution - should be addressed to WHO Press, at the above address (fax: +41 22 791 4806; email: permissions@who.int). The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. The mention of specific companies or of certain manufacturers' products does not imply that they are endorsed or recommended by the World Health Organization in preference to others of a similar nature that are not mentioned. Errors and omissions excepted, the names of proprietary products are distinguished by initial capital letters. All reasonable precautions have been taken by WHO to verify the information contained in this publication. However, the published material is being distributed without warranty of any kind, either express or implied. The responsibility for the interpretation and use of the material lies with the reader. In no event shall the World Health Organization be liable for damages arising from its use.
- URL
- https://www.who.int/about/policies/publishing/copyright
LOINC Copyright
Copyright © 2024 Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright